Michael Matson

Stock Analyst at Needham

(1.66)
# 2,326
Out of 4,667 analysts
21
Total ratings
66.67%
Success rate
12.41%
Average return

Stocks Rated by Michael Matson

Teleflex
Jan 31, 2020
Maintains: Buy
Price Target: $408$423
Current: $187.43
Upside: +125.68%
Inogen
Nov 6, 2019
Upgrades: Buy
Price Target: $90
Current: $9.46
Upside: +851.37%
Merit Medical Systems
Apr 20, 2018
Initiates: Buy
Price Target: $53
Current: $104.08
Upside: -49.08%
Globus Medical
Apr 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $83.59
Upside: -
ResMed
Jan 23, 2018
Upgrades: Hold
Price Target: n/a
Current: $241.55
Upside: -
Boston Scientific
Dec 8, 2017
Upgrades: Strong Buy
Price Target: n/a
Current: $90.17
Upside: -
LivaNova
Sep 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $50.05
Upside: -
Stryker
Aug 25, 2017
Upgrades: Hold
Price Target: n/a
Current: $385.68
Upside: -
Mobileye
Mar 14, 2017
Downgrades: Hold
Price Target: n/a
Current: $16.92
Upside: -
Hologic
Feb 15, 2017
Upgrades: Buy
Price Target: n/a
Current: $78.04
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $2.81
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $1.56
Upside: -